ZONISADE
NDC 52652-8001, ZONISAMIDE, suspension, from Azurity Pharmaceuticals, Inc..
- Product NDC
- 52652-8001
- Status
- Listed
- Labeler
- Azurity Pharmaceuticals, Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA214273
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/52652-8001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZONISAMIDE100 mg/5mL
Pharmacologic classes
Anti-epileptic Agent [EPC]; Carbonic Anhydrase Inhibitors [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; P-Glycoprotein Inhibitors [MoA]; Sulfonamides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 52652-8001-1 | 52652800101 | 1 BOTTLE in 1 CARTON (52652-8001-1) / 150 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ac16fa15-32e9-4f92-8bc6-d8d41ae002c6NADAC price for package 52652800101
GET /v1/drugs/nadac/52652800101
Use it
Look up 52652-8001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/52652-8001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 52652-8001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.